Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European marketsHy...
Wells Fargo analyst Larry Biegelsen maintains Hyperfine (NASDAQ:HYPR) with a Equal-Weight and raises the price target from $...
Lake Street analyst Frank Takkinen maintains Hyperfine (NASDAQ:HYPR) with a Buy and raises the price target from $1.5 to $2.
Hyperfine (NASDAQ:HYPR) affirms FY2025 sales outlook from $14.179 million-$15.468 million to $14.179 million-$15.468 million vs...
Hyperfine (NASDAQ:HYPR) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 14.2...
NEURO PMR study evaluates the clinical utility and patient experience of AI-powered portable MRI in an outpatient settingHyperf...
The real-world study will assess the clinical and operational impact of portable MRI across diverse patient types in ED setting...
